FDA Accepts Supplement Application for Bosentan by Natco Pharma
The FDA has accepted a supplemental application for Bosentan submitted by Natco Pharma.
Company
Pharmaceutical intelligence for Natco Pharma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.